| 臺大學術典藏 |
2021-08-24T08:01:28Z |
MiRNA-203 modulates aldosterone levels and cell proliferation by targeting wnt5a in aldosterone-producing adenomas
|
Peng K.-Y.; Chang H.-M.; Lin Y.-F.; CHIEH-KAI CHAN; Chang C.-H.; Chueh S.-C.J.; Yang S.-Y.; Huang K.-H.; Lin Y.-H.; Wu V.-C.; Wu K.-D. |
| 臺大學術典藏 |
2021-08-24T08:01:28Z |
Targeted treatment of primary aldosteronism – The consensus of Taiwan Society of Aldosteronism
|
Huang K.-H.; Yu C.-C.; Hu Y.-H.; Chang C.-C.; CHIEH-KAI CHAN; Liao S.-C.; Tsai Y.-C.; Jeff Chueh S.-C.; Wu V.-C.; Lin Y.-H.; Lin J.-H.; Wang W.-J.; Wu C.-H.; Er L.K.; Chang C.-H.; Chang Y.-L.; Ho Y.-L.; Chang H.-W.; Lin L.-Y.; Hu F.-C.; Liu K.-L.; Wang S.-M.; Lu C.-C.; Yen R.-F.; Wu K.-D.; TAIPAI, Taiwan Primary Aldosteronism Investigator |
| 臺大學術典藏 |
2021-08-24T08:01:29Z |
Kidney dysfunction associated with tenofovir exposure in human immunodeficiency virus-1-infected Taiwanese patients
|
Huang Y.-S.; CHIEH-KAI CHAN; Tsai M.-S.; Lee K.-Y.; Lin S.-W.; Chang S.-Y.; Hung C.-C.; Chang S.-C. |
| 臺大學術典藏 |
2021-08-24T08:01:29Z |
Early initiation of immunosuppressive treatment in membranous nephropathy patients
|
CHIEH-KAI CHAN; Lai T.S.; Chen P.M.; Chou Y.H.; Wu C.F.; Chiu Y.L.; Chiang W.C.; Chen Y.M.; Chu T.-S.; Wu K.D. |
| 臺大學術典藏 |
2021-08-24T08:01:29Z |
Reply
|
CHIEH-KAI CHAN; Lai T.-S.; Wu V. |
| 臺大學術典藏 |
2021-08-24T08:01:30Z |
Membranous nephropathy: A review on the pathogenesis, diagnosis, and treatment
|
Lai W.L.; Yeh T.H.; Chen P.M.; CHIEH-KAI CHAN; Chiang W.C.; Chen Y.M.; Wu K.D.; Tsai T.J. |
| 臺大學術典藏 |
2021-08-24T08:21:11Z |
Effects of Proximal Priority and Distal Priority Robotic Priming Techniques With Impairment-Oriented Training of Upper Limb Functions in Patients With Chronic Stroke: Study Protocol For A Single-Blind, Randomized Controlled Trial.
|
Lee, Y-C., Li, Y-C., LIN, K-C*., Chen C-L., Wu, Y-H., Kuo, C-C., Yeh, Y-P., Liu, T-X. |
| 臺大學術典藏 |
2021-08-24T08:23:26Z |
Increasing New Delhi metallo-β-lactamase-positive Escherichia coli among carbapenem non-susceptible Enterobacteriaceae in Taiwan during 2016 to 2018
|
YU-SHAN HUANG; Tsai W.-C.; Li J.-J.; Chen P.-Y.; Wang J.-T.; Chen Y.-T.; Chen F.-J.; Lauderdale T.-L.; Chang S.-C. |
| 臺大學術典藏 |
2021-08-24T08:23:26Z |
A cross-sectional seroprevalence for COVID-19 among healthcare workers in a tertially care hospital in Taiwan
|
Pan S.-C.; YU-SHAN HUANG; Hsieh S.-M.; Chen Y.-C.; Chang S.-Y.; Chang S.-C. |
| 臺大學術典藏 |
2021-08-24T08:23:26Z |
High rates of misidentification of uncommon Candida species causing bloodstream infections using conventional phenotypic methods
|
YU-SHAN HUANG; Wang F.-D.; Chen Y.-C.; Huang Y.-T.; Hsieh M.-H.; Hii I.-M.; Lee Y.-L.; Ho M.-W.; Liu C.-E.; Chen Y.-H.; Liu W.-L. |
| 臺大學術典藏 |
2021-08-24T08:23:27Z |
Experience of the use of hydroxychloroquine on patients with COVID-19: A perspective on viral load and cytokine kinetics
|
Liu W.-D.; Chang S.-Y.; Lan T.-Y.; Lin Y.-C.; Kao J.-H.; Liao C.-H.; Tsai M.-J.; Kuo P.-H.; YU-SHAN HUANG; Wang J.-T.; Sheng W.-H.; Hsieh S.-C.; Chiang B.-L.; Chen Y.-C.; Chang S.-C. |
| 臺大學術典藏 |
2021-08-24T08:23:27Z |
Efficacy and Safety of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide as Maintenance Treatment in HIV/HBV-Coinfected Patients
|
YU-SHAN HUANG; Cheng C.-Y.; Liou B.-H.; Lu P.-L.; Cheng S.-H.; Lee Y.-T.; Liu C.-E.; Sun H.-Y.; Yang C.-J.; Tang H.-J.; Lin S.-P.; Ho M.-W.; Huang S.-H.; Tsai H.-C.; Lee C.-H.; Hung C.-C.; Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-08-24T08:23:28Z |
Incidence and impact of low-level viremia among people living with HIV who received protease inhibitor- or dolutegravir-based antiretroviral therapy
|
Chen G.-J.; Sun H.-Y.; Chang S.-Y.; Cheng A.; YU-SHAN HUANG; Huang S.-H.; Huang Y.-C.; Su Y.-C.; Liu W.-C.; Hung C.-C. |
| 臺大學術典藏 |
2021-08-24T08:23:28Z |
Reversal of Viral Latency and Induction of Gag-Specific T-Cell Responses in HIV-1-Infected Adults Through Cyclic Treatment Interruption of Rosuvastatin: A Proof-of-Concept Study
|
Hsieh S.-M.; Pan S.-C.; YU-SHAN HUANG; Chang S.-C. |
| 臺大學術典藏 |
2021-08-24T08:23:28Z |
Hepatitis B virus seroprevalence among HIV-infected patients receiving combination antiretroviral therapy three decades after universal neonatal hepatitis B immunization program in Taiwan
|
Lin J.-J.; Lin K.-Y.; Tang H.-J.; Lin S.-P.; Lee Y.-C.; Liu C.-E.; YU-SHAN HUANG; Wang N.-C.; Li C.-W.; Ko W.-C.; Yang H.-J.; Lee Y.-T.; Hung C.-C.; Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-08-24T08:23:28Z |
Safety and immunogenicity of a Recombinant Stabilized Prefusion SARS-CoV-2 Spike Protein Vaccine (MVC[sbnd]COV1901) Adjuvanted with CpG 1018 and Aluminum Hydroxide in healthy adults: A Phase 1, dose-escalation study
|
Hsieh S.-M.; Liu W.-D.; YU-SHAN HUANG; Lin Y.-J.; Hsieh E.-F.; Lian W.-C.; Chen C.; Janssen R.; Shih S.-R.; Huang C.-G.; Tai I.-C.; Chang S.-C. |
| 臺大學術典藏 |
2021-08-24T08:23:29Z |
Impact of initiation of combination antiretroviral therapy according to the WHO recommendations on the survival of HIV-positive patients in Taiwan
|
Liu W.-D.; Tsai W.-C.; Hsu W.-T.; Shih M.-C.; Chen M.-Y.; Sun H.-Y.; Hsieh S.-M.; Sheng W.-H.; Chuang Y.-C.; Cheng A.; Lin K.-Y.; YU-SHAN HUANG; Huang S.-H.; Huang Y.-C.; Chen G.-J.; Wu P.-Y.; Hung C.-C.; Chang S.-C. |
| 臺大學術典藏 |
2021-08-24T08:23:29Z |
Advance in the treatment of HCV infection in HIV-infected patients
|
YU-SHAN HUANG; Sheng W.-H. |
| 臺大學術典藏 |
2021-08-24T08:23:29Z |
Infection prevention and control for coronavirus disease 2019 (COVID-19) in hospital settings
|
YU-SHAN HUANG; Wang J.-T.; Hung L.-C.; Huang Y.-H.; Sheng W.-H.; Chen Y.-C.; Chang S.-C. |
| 臺大學術典藏 |
2021-08-24T08:23:30Z |
Trends of recent hepatitis C virus infection among HIV-positive men who have sex with men in Taiwan, 2011–2018
|
Ho S.-Y.; Su L.-H.; Sun H.-Y.; YU-SHAN HUANG; Chuang Y.-C.; Huang M.-H.; Liu W.-C.; Su Y.-C.; Lin P.-H.; Chang S.-Y.; Hung C.-C. |
| 臺大學術典藏 |
2021-08-24T08:23:30Z |
Seroepidemiology of the human herpesvirus 8 infection among people living with HIV in Taiwan, 2014–2018
|
Tsai M.-J.; Sun H.-Y.; Hsieh S.-M.; Sheng W.-H.; Chuang Y.-C.; YU-SHAN HUANG; Huang S.-H.; Su L.-H.; Su Y.-C.; Liu W.-C.; Chang S.-Y.; Hung C.-C. |
| 臺大學術典藏 |
2021-08-24T08:23:30Z |
Renin-angiotensin-aldosterone system inhibitors and risks of severe acute respiratory syndrome coronavirus 2 infection: A systematic review and meta-analysis
|
Chan C.-K.; YU-SHAN HUANG; Liao H.-W.; Tsai I.-J.; Sun C.-Y.; Pan H.-C.; Chueh J.S.; Wang J.-T.; Wu V.-C.; Chu T.-S. |
| 臺大學術典藏 |
2021-08-24T08:23:30Z |
Colonization With Multidrug-Resistant Organisms Among Healthy Adults in the Community Setting: Prevalence, Risk Factors, and Composition of Gut Microbiome
|
YU-SHAN HUANG; Lai L.-C.; Chen Y.-A.; Lin K.-Y.; Chou Y.-H.; Chen H.-C.; Wang S.-S.; Wang J.-T.; Chang S.-C. |
| 臺大學術典藏 |
2021-08-24T08:23:31Z |
Short-term outcomes of rapid initiation of antiretroviral therapy among HIV-positive patients: Real-world experience from a single-centre retrospective cohort in Taiwan
|
Huang Y.-C.; Sun H.-Y.; Chuang Y.-C.; YU-SHAN HUANG; Lin K.-Y.; Huang S.-H.; Chen G.-J.; Luo Y.-Z.; Wu P.-Y.; Liu W.-C.; Hung C.-C.; Chang S.-C. |
| 臺大學術典藏 |
2021-08-24T08:23:31Z |
Long-term virological and serologic responses of chronic hepatitis B virus infection to tenofovir disoproxil fumarate-containing regimens in patients with HIV and hepatitis B coinfection
|
YU-SHAN HUANG; Sun H.-Y.; Chang S.-Y.; Chuang Y.-C.; Cheng A.; Huang S.-H.; Huang Y.-C.; Chen G.-J.; Lin K.-Y.; Su Y.-C.; Liu W.-C.; Hung C.-C. |
